ABP-700

DRUG3 trials

Sponsors

The Medicines Company, Annovation Biopharma, a wholly owned subsidiary of The Medicines Company, The Medicines Company, University Medical Center Groningen (UMCG)

Conditions

ColonoscopyMonitored anesthesia care (MAC) and/or general anesthesia.Preliminary safety study

Phase 2

Study to Investigate the Safety and Efficacy of 3 Dosing Regimens of ABP-700 for Procedural Sedation in Adult Participants Undergoing Colonoscopy

CompletedNCT02800590

The Medicines CompanyColonoscopy

Start: 2016-05-31End: 2017-06-30Updated: 2018-02-20

Unknown Phase

A Phase 1, Single-Center, Open-Label, Dose Optimization Study of ABP-700 in Healthy, Adult Subjects

RecruitingNL-OMON25663

Annovation Biopharma, a wholly owned subsidiary of The Medicines CompanyPreliminary safety study

Start: 2015-05-19Target: 80Updated: 2024-02-28

A Phase 1, Single-Center, Open-label, Infusion Dose Optimization Study of ABP-700 in Healthy, Adult Subjects

Active, not recruitingNL-OMON26835

The Medicines Company, University Medical Center Groningen (UMCG)Monitored anesthesia care (MAC) and/or general anesthesia.

Start: 2015-08-03Target: 80Updated: 2024-02-28